27.97
price down icon4.23%   -1.235
after-market Dopo l'orario di chiusura: 28.36 0.39 +1.39%
loading

Alumis Inc Borsa (ALMS) Ultime notizie

pulisher
Feb 20, 2026

A | What is Alumis Inc.'s debt-to-equity ratio2025 Macro Impact & Fast Moving Trade Plans - mfd.ru

Feb 20, 2026
pulisher
Feb 20, 2026

Big Picture: Is Alumis Inc in a consolidation phaseWeekly Trend Report & Long-Term Growth Plans - baoquankhu1.vn

Feb 20, 2026
pulisher
Feb 20, 2026

Alumis Inc stock hits all-time high at 28.34 USD By Investing.com - Investing.com India

Feb 20, 2026
pulisher
Feb 19, 2026

Alumis (NASDAQ:ALMS) Sets New 52-Week HighStill a Buy? - MarketBeat

Feb 19, 2026
pulisher
Feb 19, 2026

Alumis Inc stock hits all-time high at 28.34 USD - Investing.com

Feb 19, 2026
pulisher
Feb 19, 2026

Alumis Inc. (ALMS): Investor Outlook Reveals 35% Upside Potential In Biotech Sector - DirectorsTalk Interviews

Feb 19, 2026
pulisher
Feb 18, 2026

Risk Hedge: Is Alumis Inc gaining market shareJuly 2025 Retail & Technical Pattern Based Buy Signals - baoquankhu1.vn

Feb 18, 2026
pulisher
Feb 17, 2026

Huge insider buying now at this insurance giant and 2 biotechs - MSN

Feb 17, 2026
pulisher
Feb 16, 2026

Alumis Stock: Key Catalysts on the Horizon for 2026 - AD HOC NEWS

Feb 16, 2026
pulisher
Feb 16, 2026

Credit Industriel ET Commercial Sells 140,000 Shares of Alumis Inc. $ALMS - MarketBeat

Feb 16, 2026
pulisher
Feb 14, 2026

Why Alumis Inc. stock is trending among retail tradersJuly 2025 Fed Impact & Weekly High Conviction Trade Ideas - mfd.ru

Feb 14, 2026
pulisher
Feb 12, 2026

Can Alumis Inc. expand into new markets2025 Momentum Check & Short-Term Swing Trade Alerts - mfd.ru

Feb 12, 2026
pulisher
Feb 12, 2026

Alumis (NASDAQ:ALMS) Shares Up 7.2%Still a Buy? - MarketBeat

Feb 12, 2026
pulisher
Feb 12, 2026

Alumis Highlights Phase III Psoriasis Wins, NDA Timing, and Lupus Catalyst at Guggenheim Summit - MarketBeat

Feb 12, 2026
pulisher
Feb 11, 2026

Is Alumis Inc.’s growth already priced inPortfolio Growth Summary & Weekly Watchlist of Top Performers - mfd.ru

Feb 11, 2026
pulisher
Feb 10, 2026

Quarterly Risk: Is Alumis Inc in a consolidation phase2025 Price Action Summary & Growth Focused Entry Reports - baoquankhu1.vn

Feb 10, 2026
pulisher
Feb 09, 2026

Can Alumis Inc. ride the EV wave2025 Pullback Review & Weekly High Potential Stock Alerts - mfd.ru

Feb 09, 2026
pulisher
Feb 08, 2026

Alumis Stock Has Rallied 250% This Past Year. One Fund Sold Its $5 Million Stake Last Quarter. - AOL.com

Feb 08, 2026
pulisher
Feb 07, 2026

Alumis (ALMS) Valuation Check After Strong Multi‑Month Share Price Momentum - Yahoo Finance

Feb 07, 2026
pulisher
Feb 06, 2026

EPS Watch: Can Alumis Inc ride the EV waveWeekly Stock Analysis & Expert Approved Momentum Trade Ideas - baoquankhu1.vn

Feb 06, 2026
pulisher
Feb 06, 2026

Market Leaders: Will TWFG outperform the market in YEARTrade Analysis Report & High Win Rate Trade Alerts - baoquankhu1.vn

Feb 06, 2026
pulisher
Feb 06, 2026

Alumis Ownership Shifts As Shelf Filing And Conferences Shape Outlook - Sahm

Feb 06, 2026
pulisher
Feb 05, 2026

Alumis to Participate in Upcoming February Investor Conferences - The Manila Times

Feb 05, 2026
pulisher
Feb 04, 2026

Alumis Inc. (NASDAQ:ALMS) Receives Consensus Recommendation of "Moderate Buy" from Brokerages - MarketBeat

Feb 04, 2026
pulisher
Feb 02, 2026

Alumis and ACELYRIN announce merger in all-stock deal - MSN

Feb 02, 2026
pulisher
Feb 02, 2026

Alumis (NASDAQ:ALMS) Stock Price Up 9.8%What's Next? - MarketBeat

Feb 02, 2026
pulisher
Feb 02, 2026

Alumis Inc stock (ALMS) jumps again on Nasdaq — here’s what’s driving the move and what comes next - TechStock²

Feb 02, 2026
pulisher
Feb 02, 2026

Why Alumis Inc. Stock Is Suddenly Powering Higher - TipRanks

Feb 02, 2026
pulisher
Jan 31, 2026

Chardan highlights Alumis’s (ALMS) potential after envudeucitinib hits all phase 3 endpoints in psoriasis trials - MSN

Jan 31, 2026
pulisher
Jan 30, 2026

Alumis Inc. (ALMS) Stock Price | Live Quotes & Charts | NASDAQ - StocksToTrade

Jan 30, 2026
pulisher
Jan 30, 2026

Top Small Cap Stocks To Watch NowJanuary 6th - MarketBeat

Jan 30, 2026
pulisher
Jan 30, 2026

Chardan Highlights Alumis's (ALMS) Potential After Envudeucitinib Hits All Phase 3 Endpoints in Psoriasis Trials - Finviz

Jan 30, 2026
pulisher
Jan 30, 2026

Chardan Highlights Alumis’s (ALMS) Potential After Envudeucitinib Hits All Phase 3 Endpoints in Psoriasis Trials - Insider Monkey

Jan 30, 2026
pulisher
Jan 30, 2026

Alumis Inc. (NASDAQ:ALMS) Short Interest Up 93.1% in January - MarketBeat

Jan 30, 2026
pulisher
Jan 29, 2026

Alumis stock hits all-time high at 27.28 USD By Investing.com - Investing.com Australia

Jan 29, 2026
pulisher
Jan 29, 2026

Alumis Inc. (ALMS) Stock Analysis: A Biotech Contender With A 34.43% Potential Upside - DirectorsTalk Interviews

Jan 29, 2026
pulisher
Jan 29, 2026

10 New Stocks on the Rise - Insider Monkey

Jan 29, 2026
pulisher
Jan 28, 2026

Alumis (NASDAQ:ALMS) Hits New 12-Month HighStill a Buy? - MarketBeat

Jan 28, 2026
pulisher
Jan 28, 2026

Alumis stock hits all-time high at 27.28 USD - Investing.com

Jan 28, 2026
pulisher
Jan 26, 2026

Alumis (NASDAQ:ALMS) Trading Up 6.4%Should You Buy? - MarketBeat

Jan 26, 2026
pulisher
Jan 26, 2026

Stock Market Today, Jan. 6: Alumis Shares Surge on Positive Phase 3 Psoriasis Data for Envudeucitinib - AOL.com

Jan 26, 2026
pulisher
Jan 22, 2026

Alumis (NASDAQ:ALMS) Coverage Initiated by Analysts at Chardan Capital - MarketBeat

Jan 22, 2026
pulisher
Jan 21, 2026

Alumis stock reaches all-time high at 25.25 USD By Investing.com - Investing.com Australia

Jan 21, 2026
pulisher
Jan 21, 2026

This Crescent Biopharma Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Wednesday - Benzinga

Jan 21, 2026
pulisher
Jan 21, 2026

Chardan Capital initiates coverage on Alumis stock with Buy rating - Investing.com

Jan 21, 2026
pulisher
Jan 21, 2026

Chardan Capital initiates coverage on Alumis stock with Buy rating By Investing.com - Investing.com Nigeria

Jan 21, 2026
$49.87
price up icon 0.34%
$101.83
price down icon 0.89%
$101.32
price down icon 0.40%
$110.14
price down icon 0.25%
$164.91
price up icon 2.43%
biotechnology ONC
$362.14
price up icon 2.16%
Capitalizzazione:     |  Volume (24 ore):